Cargando…

Biomechanical Regulatory Factors and Therapeutic Targets in Keloid Fibrosis

Keloids are fibroproliferative skin disorder caused by abnormal healing of injured or irritated skin and are characterized by excessive extracellular matrix (ECM) synthesis and deposition, which results in excessive collagen disorders and calcinosis, increasing the remodeling and stiffness of keloid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Fan, Liu, Mingying, Pan, Lianhong, Wu, Jiaqin, Wang, Chunli, Yang, Li, Liu, Wanqian, Xu, Wei, Lei, Mingxing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124765/ https://www.ncbi.nlm.nih.gov/pubmed/35614943 http://dx.doi.org/10.3389/fphar.2022.906212

Ejemplares similares

Schisantherin A inhibits cell proliferation by regulating glucose metabolism pathway in hepatocellular carcinoma
por: Feng, Fan, et al.
Publicado: (2022)

Hesperetin Exhibits Anti-Inflammatory Effects on Chondrocytes via the AMPK Pathway to Attenuate Anterior Cruciate Ligament Transection-Induced Osteoarthritis
por: Wu, Jiaqin, et al.
Publicado: (2021)

Therapeutic Strategies by Regulating Interleukin Family to Suppress Inflammation in Hypertrophic Scar and Keloid
por: Zhang, Dan, et al.
Publicado: (2021)

Integrins and cadherins as therapeutic targets in fibrosis
por: Agarwal, Sandeep K.
Publicado: (2014)

Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis
por: Samuel, Chrishan S., et al.
Publicado: (2017)

Pharmacological modulation of ferroptosis as a therapeutic target for liver fibrosis
por: Li, Le, et al.
Publicado: (2023)

Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis
por: Tesch, Greg H., et al.
Publicado: (2017)

Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis
por: Estornut, Cristina, et al.
Publicado: (2022)

Cepharanthine inhibits hepatocellular carcinoma cell growth and proliferation by regulating amino acid metabolism and suppresses tumorigenesis in vivo
por: Feng, Fan, et al.
Publicado: (2021)

Targeting Mechanotransduction at the Transcriptional Level: YAP and BRD4 Are Novel Therapeutic Targets for the Reversal of Liver Fibrosis
por: Zhubanchaliyev, Altynbek, et al.
Publicado: (2016)

Editorial: Molecular Mechanisms and New Therapeutic Targets in Epithelial to Mesenchymal Transition (EMT) and Fibrosis
por: Battistelli, Cecilia, et al.
Publicado: (2020)

Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis
por: Ma, Hongbo, et al.
Publicado: (2022)

Immunometabolism changes in fibrosis: from mechanisms to therapeutic strategies
por: Feng, Lixiang, et al.
Publicado: (2023)

Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies
por: Xu, Jie, et al.
Publicado: (2020)

Therapeutic potential of topical administration of acriflavine against hypoxia-inducible factors for corneal fibrosis
por: Zhu, Shuyan, et al.
Publicado: (2022)

Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis
por: Ma, Hongbo, et al.
Publicado: (2022)

Targeting Hypoxia Inducible Factors-1α As a Novel Therapy in Fibrosis
por: Xiong, Anji, et al.
Publicado: (2017)

Therapeutic Potential of Polyphenols in Cardiac Fibrosis
por: Zhang, Ning, et al.
Publicado: (2018)

Targeting Calcium Homeostasis in Myocardial Ischemia/Reperfusion Injury: An Overview of Regulatory Mechanisms and Therapeutic Reagents
por: Wang, Ruiying, et al.
Publicado: (2020)

Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis
por: Lee, Suh-Young, et al.
Publicado: (2022)

Drugs and Targets in Fibrosis
por: Li, Xiaoyi, et al.
Publicado: (2017)

Corrigendum: Therapeutic potential of topical administration of acriflavine against hypoxia-inducible factors for corneal fibrosis
por: Zhu, Shuyan, et al.
Publicado: (2023)

The Biomechanics and Optimization of the Needle-Syringe System for Injecting Triamcinolone Acetonide into Keloids
por: Vo, Anthony, et al.
Publicado: (2016)

Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis
por: Li, Shan-Shan, et al.
Publicado: (2021)

Emerging Therapeutic Strategies for Attenuating Tubular EMT and Kidney Fibrosis by Targeting Wnt/β-Catenin Signaling
por: Hu, Lichao, et al.
Publicado: (2022)

Editorial: Molecular mechanisms and new therapeutic targets in epithelial to mesenchymal transition (EMT) and fibrosis, volume II
por: Battistelli, Cecilia, et al.
Publicado: (2022)

Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2019)

Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora
por: Liu, Xianzhi, et al.
Publicado: (2022)

Epac: A Promising Therapeutic Target for Vascular Diseases: A Review
por: Pan, Yunfeng, et al.
Publicado: (2022)

Isorhamnetin attenuates the proliferation, invasion, migration and fibrosis of keloid fibroblasts by targeting S1PR1
por: Pu, Xiaoshu, et al.
Publicado: (2023)

Role of the SLC26A9 Chloride Channel as Disease Modifier and Potential Therapeutic Target in Cystic Fibrosis
por: Balázs, Anita, et al.
Publicado: (2018)

Risk factors associated with the progression from keloids to severe keloids
por: Liu, Ruolin, et al.
Publicado: (2022)

Emerging microRNA Therapeutic Approaches for Cystic Fibrosis
por: Bardin, Pauline, et al.
Publicado: (2018)

Is There a Potential Therapeutic Role for Caveolin-1 in Fibrosis?
por: Shihata, Waled A., et al.
Publicado: (2017)

A potential therapeutic target in traditional Chinese medicine for ulcerative colitis: Macrophage polarization
por: Yang, Zhihua, et al.
Publicado: (2022)

Initial therapeutic target attainment of perampanel in pediatric patients with epilepsy
por: Yu, Lingyan, et al.
Publicado: (2023)

Matrix Mechanics as Regulatory Factors and Therapeutic Targets in Hepatic Fibrosis
por: Chen, Guobao, et al.
Publicado: (2019)

PARP1 Inhibition as a Novel Therapeutic Target for Keloid Disease
por: Park, Tae Hwan, et al.
Publicado: (2019)

Metabolic reprogramming: A novel therapeutic target in diabetic kidney disease
por: Wang, Mengdi, et al.
Publicado: (2022)

Therapeutic strategies for preventing skeletal muscle fibrosis after injury
por: Garg, Koyal, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_oe0g4jsfo76hqvfn6heib3tp61